Cite
MLA Citation
E Clarke et al.. “P24 Regional experience of indications for switching patients to raltegravir and maraviroc and success after regimen change.” Sexually transmitted infections, vol. 88, n.d., p. A18. http://access.bl.uk/ark:/81055/vdc_100137793603.0x000015